DE3231087A1 - Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel - Google Patents

Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Info

Publication number
DE3231087A1
DE3231087A1 DE19823231087 DE3231087A DE3231087A1 DE 3231087 A1 DE3231087 A1 DE 3231087A1 DE 19823231087 DE19823231087 DE 19823231087 DE 3231087 A DE3231087 A DE 3231087A DE 3231087 A1 DE3231087 A1 DE 3231087A1
Authority
DE
Germany
Prior art keywords
mycobacterium
fraction
tumor
deoxyribonucleic acid
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823231087
Other languages
German (de)
English (en)
Other versions
DE3231087C2 (enrdf_load_stackoverflow
Inventor
Tamotsu Fukuda
Yoshio Furutani
Shizuo Shimada
Hiroshi Yamamoto
Osamu Mobara Chiba Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to DE19823231087 priority Critical patent/DE3231087A1/de
Publication of DE3231087A1 publication Critical patent/DE3231087A1/de
Application granted granted Critical
Publication of DE3231087C2 publication Critical patent/DE3231087C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19823231087 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel Granted DE3231087A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19823231087 DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823231087 DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Publications (2)

Publication Number Publication Date
DE3231087A1 true DE3231087A1 (de) 1984-02-23
DE3231087C2 DE3231087C2 (enrdf_load_stackoverflow) 1987-08-06

Family

ID=6171365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823231087 Granted DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Country Status (1)

Country Link
DE (1) DE3231087A1 (enrdf_load_stackoverflow)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Biochemical Journal 62, 315, 1956 *
Cancer Research 27, 2342, 1967 *
Infection and Immunity 14, 929, 1976 *
Journal of Molecular Biology 3, 208, 1961 *
Proceedings of the National Academy of Science 61, 207, 1968 *
Science, 149, 997, 1965 *

Also Published As

Publication number Publication date
DE3231087C2 (enrdf_load_stackoverflow) 1987-08-06

Similar Documents

Publication Publication Date Title
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE4323567B4 (de) Aucubin zur Behandlung einer Hepatitis-B-Virus-Infektion
DE3407823C2 (enrdf_load_stackoverflow)
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE60225349T2 (de) Immunstimulierende und regulierende zusammensetzung mit bakteriellen chromosomalen dna-fragmenten und nichttoxischen lipopolysacchariden
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE60218473T2 (de) Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen
CH641354A5 (de) Material mit antitumorwirkung und verfahren zu dessen herstellung.
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
DE2930604A1 (de) Doppelstrangige ribonucleinsaeure, verfahren zu ihrer herstellung und diese enthaltende interferon-induktoren
DE2723451C2 (enrdf_load_stackoverflow)
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE1617397C3 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
DE2425997A1 (de) Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin
Hinz Beitrag zur differenzierung von haemophilus‐stämmen aus hühnern* I. mitteilung: Kulturelle und biochemische untersuchungen
DE3231087C2 (enrdf_load_stackoverflow)
DE2152112C3 (de) Impfstoff gegen Pseudomonas aeruginosa
US4579941A (en) Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
DE2403733A1 (de) Neue lipopolysaccharide und verfahren zu ihrer herstellung
DE3323093C2 (de) Pharmazeutisches Präparat zur Bekämpfung von Tumoren
DE1617659A1 (de) Polynucleotide,welche als die Interferonerzeugung in lebenden tierischen Zellen induzierende Verbindungen wirksam sind
DE1963998A1 (de) Interferon induzierendes Mittel,Verfahren zu seiner Herstellung und Verfahren zur Interferon-Induktion durch Verwendung dieses Mittels
CA1190164A (en) Thermally-denatured deoxyribonucleic acid md-o11 and antitumor agent
DE3885655T2 (de) Antibiotikum 6270B, Verfahren zu seiner Herstellung und seine Verwendung als Anticoccidiosemittel und Futterzusatz.

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee